Plain-English translation of NCT06865144 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a medication called Rhopressa works better at lowering eye pressure when added after a laser eye surgery called selective laser trabeculoplasty. Some patients still need additional pressure reduction even after the laser treatment, so researchers want to know if this medication can provide extra benefit when combined with the surgery.
Although the laser surgery and this medication both work on the same part of the eye, doctors don't fully understand how well they work together. This study will help eye doctors decide whether to prescribe this treatment to patients who have had the laser surgery but still need their eye pressure lowered more.
You will visit the clinic three times over 6 weeks (or up to 12 weeks if you need time to stop previous medications). At each visit, your eye pressure will be measured and your eyes will be examined. You will be randomly assigned to either receive the new eye drop medication or (placebo), and neither you nor the researchers will know which one you're using. You will use your assigned drops as directed throughout the study period.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States